Toward a pathway-centered approach for the treatment of adrenocortical carcinoma
Authors:
- Kimberly J BusseyKBKimberly J Bussey
- Michael J DemeureMDMichael J Demeure
- 1 January 2011
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Oncology
- Vol. 23 (1) , 34-44
Abstract
Adrenocortical carcinoma is an aggressive, lethal malignancy of the adrenal cortex. The rarity of the disease has stymied therapeutic development. Recent work toward understanding the molecular pathogenesis of the disease has identified several potential new diagnostic and therapeutic targets. The molecular characterization of adrenocortical carcinoma has identified dysregulation of the Gap 2/mitosis transition and the insulin-like growth factor 1 receptor signaling cascade as two major pathways for therapeutic development. These studies have also highlighted an unappreciated heterogeneity of the disease at the gene level that nevertheless seems to converge onto common cellular pathways. Additionally, the characterization of Wnt signaling through β-catenin in adrenal development, the demonstration of the involvement of BMP signaling in adrenocortical carcinoma growth regulation, and the discovery that ERCC1 expression levels can predict therapeutic response to platinum are just a few of the recent advances that promise to shed light on adrenocortical carcinoma biology. Short-term, therapeutic development should target the Gap 2/mitosis transition and the downstream signaling of the insulin-like growth factor 1 receptor receptor. Long-term, additional characterization of patient samples, particularly at the sequence level, is required to fully understand adrenocortical carcinoma biology and apply that knowledge to clinical practice.Keywords
This publication has 43 references indexed in Scilit:
- Regulation of Insulin-like Growth Factor–Mammalian Target of Rapamycin Signaling by MicroRNA in Childhood Adrenocortical TumorsCancer Research, 2010
- miR-195 and miR-483-5p Identified as Predictors of Poor Prognosis in Adrenocortical CancerClinical Cancer Research, 2009
- Transcriptional profiling enables molecular classification of adrenocortical tumoursEuropean Journal of Endocrinology, 2009
- Genomic and Expression Profiling of Adrenocortical Carcinoma: Application to Diagnosis, Prognosis and TreatmentFuture Oncology, 2009
- Microarray gene expression and immunohistochemistry analyses of adrenocortical tumors identify IGF2 and Ki-67 as useful in differentiating carcinomas from adenomasEndocrine-Related Cancer, 2009
- Gene Expression Profiling Reveals a New Classification of Adrenocortical Tumors and Identifies Molecular Predictors of Malignancy and SurvivalJournal of Clinical Oncology, 2009
- Molecular Classification and Prognostication of Adrenocortical Tumors by Transcriptome ProfilingClinical Cancer Research, 2009
- Expression profiling of adrenocortical neoplasms suggests a molecular signature of malignancySurgery, 2005
- Gene Expression Profiling of Human Adrenocortical Tumors Using Complementary Deoxyribonucleic Acid Microarrays Identifies Several Candidate Genes as Markers of MalignancyThe Journal of Clinical Endocrinology & Metabolism, 2005
- Distinct Transcriptional Profiles of Adrenocortical Tumors Uncovered by DNA Microarray AnalysisThe American Journal of Pathology, 2003